Recent Press Releases

Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business

POTTERS BAR, England and PITTSBURGH, Feb. 27, 2015 /PRNewswire/ -- Mylan N.V. and Mylan Inc. (Nasdaq: MYL) today announced the successful completion of the acquisition of Abbott Laboratories'...

Phase 3 Head-to-Head ENDEAVOR Study Demonstrates Superiority Of Kyprolis® (carfilzomib) Over Velcade® (bortezomib) In Patients With Relapsed Multiple Myeloma

Study Met Primary Endpoint of Progression-Free Survival Patients Receiving Kyprolis Lived Twice as Long Without Disease Progression THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March...

Endo Reports Fourth Quarter And Full Year 2014 Financial Results

DUBLIN, March 2, 2015 /PRNewswire/ -- Full year 2014 adjusted diluted EPS exceeds top end of guidance by $0.06 Total quarterly revenues of $800 million brings full year revenues to top end of...

Novartis announces completion of transactions with GSK

Completes transactions with GSK including: acquisition of GSK oncology portfolio, creation of Consumer Healthcare joint venture, and sale of non-influenza Vaccines business Sharpens company focus...

GSK completes major three-part transaction with Novartis

£4 billion to be returned to shareholders Q1 Results & Investor Meeting to be held on 6 May 2015 GlaxoSmithKline plc (LSE/NYSE: GSK) announces that its three-part transaction with Novartis...

Novo Nordisk receives Health Canada approval for Saxenda (liraglutide) for the treatment of chronic weight management

MISSISSAUGA, ON, Feb. 26, 2015 /CNW/ - Novo Nordisk today announced that Health Canada has approved the New Drug Submission for Saxenda® (liraglutide), the first once-daily human glucagon-like...

Bayer Receives EU Approval for EYLEA for the Treatment of Retinal Vein Occlusion

BERLIN, Germany I February 26, 2015 I Bayer HealthCare announced today that EYLEA® (aflibercept solution for injection into the eye) has been approved by the European Commission for the...

Toujeo® Receives Positive Opinion from the European Regulatory Authorities

Paris, France - February 27, 2015 - Sanofi announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion...

Universal Health Services, Inc. Reports 2014 Fourth Quarter And Full Year Earnings And 2015 Earnings Guidance

Consolidated Results of Operations, As Reported - Three and twelve-month periods ended December 31, 2014 and 2013:

KING OF PRUSSIA, Pa.

Johnson & Johnson Announces Formation of New Health and Wellness Platform Designed to Transform Health Care Delivery and Improve the Patient Experience

New Patient Athlete™ Program Demonstrates Comprehensive Approach to Driving Sustained Behavior Change and Improved Outcomes

NEW BRUNSWICK

Launch of the Anti-Cancer Agent / BRAF Inhibitor "Zelboraf®" - Contribution to the Treatment of Melanoma by Personalized Healthcare -

February 25, 2015 (Tokyo) - Chugai Pharmaceutical Co., Ltd. [Main Office: Chuo-ku, Tokyo. Chairman & CEO: Osamu Nagayama (hereafter, "Chugai")] announced today that it will launch the BRAF...

NICE guidance recommends sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) for treating hepatitis C

Healthcare guidance body NICE has today published final guidance recommending sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) as treatment options for some people with chronic...

SANOFI RECEIVES FDA APPROVAL OF ONCE-DAILY BASAL INSULIN TOUJEO®

PARIS, Feb. 25, 2015 /PRNewswire-USNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL), a...

Assemblymember Chiu Introduces Bill to Lift Veil on Drug Pricing

Assemblymember Chiu Introduces Bill to Lift Veil on Drug Pricing Proposal Requires Transparency on Drug Costs for First Time Assemblymember David Chiu (D- San Francisco) introduced AB 463, which, for...

Lilly to Present at Cowen Health Care Conference

INDIANAPOLIS, Feb.

ABRAXANE® Now Reimbursed in Italy as a First-Line Treatment of Adult Patients with Metastatic Pancreatic Cancer

BOUDRY, Switzerland--(BUSINESS WIRE)-- Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (CELG), today announced that Italian authorities have issued a positive...